The present invention pertains to use of PKC-iota inhibitors for treatment of glioma. In a specific embodiment, the treatment method comprises administering ICA-1 or a salt thereof to a subject with glioma. In another embodiment, the treatment method comprises contacting glioma cells with an effective amount of ICA-1 or a salt thereof.
Acevedo-Duncan, Mildred E., "Use of PKC-iota inhibitors for the treatment of glioma" (2014). USF Patents. 111.
University of South Florida The United States of America as represented by the Department of Veterans Affairs